Together, these analyses revealed that while the pTRT cell abundance was similar in primary NSCLC and BrM, particularly melanoma–BrM and NSCLC–BrM, the pTRT cell phenotype showed some underlying disease specificity. Here, SMARCA2 is linked to melanoma.